A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration

NCT00395057 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
138
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated early due to company decision (non-safety related).

Conditions

Interventions

Sponsor

Allergan